ArticleInvestigational new drugs2025

A novel CDK4 inhibitor for myeloid protection in chemotherapy-treated triple-negative breast Cancer.

Ava Safaroghli-Azar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.